Financials

  • Market Capitalization 116.39 M
  • Employee 65
  • Founded 2007
  • CEO Niels C. Riedemann
  • Website www.inflarx.de
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Biotecnologia
Ricavi totali
Utile netto
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3796
FHTX
Foghorn Therapeutics Inc. - Common Stock
1.96 USD-2.00%-2.97%-55.56%-51.96%116.40 M USD
3797
ENGN
enGene Therapeutics Inc. - Common Stock
1.70 USD-1.73%-8.11%-5.56%-79.76%113.93 M USD
3799
COYA
Coya Therapeutics, Inc. - Common Stock
4.86 USD-1.82%-1.42%+10.71%-21.23%114.01 M USD
3805
LENZ
LENZ Therapeutics, Inc. - Common Stock
3.65 USD0.00%+4.58%-19.43%-88.77%114.68 M USD

Notizie